| Literature DB >> 21037099 |
Luke Barron1, Hans Dooms, Katrina K Hoyer, Wilson Kuswanto, Jerry Hofmann, William E O'Gorman, Abul K Abbas.
Abstract
IL-2 controls the survival of regulatory T cells (Tregs), but it is unclear whether IL-2 also directly affects Treg suppressive capacity in vivo. We have found that eliminating Bim-dependent apoptosis in IL-2- and CD25-deficient mice restored Treg numbers but failed to cure their lethal autoimmune disease, demonstrating that IL-2-dependent survival and suppressive activity can be uncoupled in Tregs. Treatment with IL-2-anti-IL-2-Ab complexes enhanced the numbers and suppressive capacity of IL-2-deprived Tregs with striking increases in CD25, CTLA-4, and CD39/CD73 expression. Although cytokine treatment induced these suppressive mechanisms in both IL-2(-/-) and IL-2(-/-)Bim(-/-) mice, it only reversed autoimmune disease in the latter. Our results suggest that successful IL-2 therapy of established autoimmune diseases will require a threshold quantity of Tregs present at the start of treatment and show that the suppressive capacity of Tregs critically depends on IL-2 even when Treg survival is independent of this cytokine.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21037099 PMCID: PMC3059533 DOI: 10.4049/jimmunol.0903940
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422